Five Questions With a16z?s Vijay Pande on AI and Making New Drugs

In startup world these days, the word ?biotech? is increasingly accompanied by ?computational? and two, two-letter initialisms: AI and ML. Those tools?artificial intelligence and machine learning, respectively?have been around for decades, but in recent years have become faster and cheaper, accelerating their use by those in the business of discovering and developing new drugs. Another [?]